The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

American Journal of Kidney Diseases

Volumn 35, Issue 2, 2000, Pages 179-188

  Fogo, Agnes B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Plasminogen activator Inhibitor 1; Renal fibrosis

Indexed keywords

ANGIOTENSIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; HOMEOSTASIS; HUMAN; KIDNEY BLOOD FLOW; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEGRADATION; REVIEW;

EID: 0033978850     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70324-6     Document Type: Article

References (79)

1. EJ Lewis LG Hunsicker RP Bain RD Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
2. DC Cattran C Greenwood S Ritchie Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy Am J Kidney Dis 23 1994 247 254
3. G Maschio D Alberti G Janin F Locatelli JFE Mann M Motolese C Ponticelli E Ritz P Zucchelli Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
4. BL Kasiske RS Kalil JZ Ma M Liao WF Keane Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis Ann Intern Med 118 1993 129 138
5. R Tanaka V Kon T Yoshioka I Ichikawa A Fogo Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms Kidney Int 45 1994 537 543
6. T Oikawa M Freeman W Lo DE Vaughan A Fogo Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition Kidney Int 51 1997 164 172
7. JE Moulder BL Fish EP Cohen SM Bonsib Angiotensin II receptor antagonists in the prevention of radiation nephropathy Radiat Res 146 1996 106 110
8. S Anderson TW Meyer HG Rennke BM Brenner Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass J Clin Invest 76 1985 612 619
9. TH Hostetter JL Olson HG Rennke MA Venkatachalam BM Brenner Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation Am J Physiol 241 1981 F85 F93
10. A Fogo Y Yoshida AD Glick T Homma I Ichikawa Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis J Clin Invest 82 1988 322 330
11. S Anderson HG Rennke BM Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1986 1993 2000
12. BM Brenner TW Meyer TH Hostetter Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 1982 652 659
13. Y Yoshida A Fogo H Shiraga AD Glick I Ichikawa Serial micropuncture analysis of single nephron function in subtotal renal ablation Kidney Int 33 1988 855 867
14. Y Yoshida A Fogo I Ichikawa Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis Kidney Int 35 1989 654 660
15. Y Yoshida T Kawamura M Ikoma A Fogo I Ichikawa Effects of antihypertensive drugs on glomerular morphology Kidney Int 36 1989 626 635
16. A Fogo EP Hawkins PL Berry AD Glick ML Chiang RC MacDonell Jr I Ichikawa Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis Kidney Int 38 1999 115 123
17. E Nyberg SO Bohman U Berg Glomerular volume and renal function in children with different types of the nephrotic syndrome Pediatr Nephrol 8 1994 285 289
18. JY Kim MK Kim HS Lee Glomerular growth in childhood focal segmental glomerulosclerosis Pediatr Nephrol 12 1998 108 112
19. M Danilewicz M Wagrowska-Danilewicz Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults: A quantitative study Pol J Pathol 47 1996 209 214
20. J Suzuki N Yoshikawa H Nakamura A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis Pediatr Nephrol 8 1994 416 419
21. T Homma RL Hoover I Ichikawa RC Harris Angiotensin II induces hypertrophy and stimulates collagen production in cultured rat glomerular mesangial cell Clin Res 38 1990 358A (abstr)
22. G Wolf U Haberstroh EG Neilson Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells Am J Pathol 140 1992 95 107
23. T Matsusaka J Hymes I Ichikawa Angiotensin in progressive renal diseases: Theory and practice J Am Soc Nephrol 7 1996 2025 2043
24. LM Harrison-Bernard LG Navar MM Ho GP Vinson SS el-Dahr Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody Am J Physiol 273 1997 F170 F177
25. R Ardaillou Angiotensin II receptors J Am Soc Nephrol 10 suppl 11 1999 S30 S39
26. AM Allen J Zhuo FA Mendelsohn Localization of angiotensin AT1 and AT2 receptors J Am Soc Nephrol 10 suppl 11 1999 S23 S29
27. T Yamada M Horiuchi VJ Dzau Angiotensin II type 2 receptor mediates programmed cell death Proc Natl Acad Sci U S A 93 1996 156 160
28. T Ichiki PA Labosky C Shiota S Okuyama Y Imagawa A Fogo F Niimura I Ichikawa BL Hogan T Inagami Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor Nature 377 1995 748 750
29. J Ma H Nishimura A Fogo V Kon T Inagami I Ichikawa Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction Kidney Int 53 1990 937 944
30. N Ohkubo H Matsubara Y Nozawa Y Mori S Murasawa K Kijima K Maruyama H Masaki Y Tsutumi Y Shibazaki T Iwasaka M Inada Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism Circulation 96 1997 3954 3962
31. M Sharma R Sharma AS Greene ET McCarthy VJ Savin Documentation of angiotensin II receptors in glomerular epithelial cells Am J Physiol 274 1998 F623 F627
32. JK Coleman LT Krebs TA Hamilton B Ong KA Lawrence MF Sardinia JW Harding JW Wright Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats Peptides 19 1998 269 277
33. D Chansel S Czekalski S Vandermeersch E Ruffet MC Fournie-Zaluski R Ardaillou Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells Am J Physiol 275 1998 F535 F542
34. M Ikoma T Kawamura Y Kakinuma A Fogo I Ichikawa Cause of variable therapeutic efficacy of angiotensin converting enzyme inhibitor on glomerular lesions Kidney Int 40 1991 195 202
35. S Nakamura I Nakamura L Ma A Fogo Regression of established glomerulosclerosis by high dose angiotensin type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1) J Am Soc Nephrol 10 1999 665A (abstr)
36. GN Marinides GC Groggel AH Cohen WA Border Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy Kidney Int 37 1990 749 757
37. MA Carome LJ Striker EP Peten J Moore CW Yang WG Stetler-Stevenson GE Striker Human glomeruli express tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA and TIMP-2 protein and mRNA Am J Physiol 264 1993 F923 F929
38. RJ Johnson J Floege WG Couser CE Alpers Role of platelet-derived growth factor in glomerular disease J Am Soc Nephrol 4 1993 119 128
39. G Wolf Angiotensin II is involved in the progression of renal disease: Importance of non-hemodynamic mechanisms Nephrologie 19 1998 451 456
40. M Ketteler NA Noble WA Border Transforming growth factor-β and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 57 1995 279 295
41. NJ Brown DE Vaughan The renin-angiotensin and fibrinolytic systems: Co-conspirators in the pathogenesis of ischemic cardiovascular disease Trends Cardiovasc Med 6 1996 239 243
42. J-D Vassalli A-P Sappino D Belin The plasminogen activator/plasmin system J Clin Invest 88 1991 1067 1072
43. L Becquemont G Nguyen M-N Peraldi C-J He J-D Sraer E Rondeau Expression of plasminogen/plasmin receptors on human glomerular epithelial cells Am J Physiol 267 1994 F303 F310
44. JJ Kanalas Analysis of the plasminogen system on rat glomerular epithelial cells Exp Cell Res 218 1995 561 566
45. RR Schleef DL Higgins E Pillemer LJ Levitt Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor J Clin Invest 83 1989 1747 1752
46. J Dieval G Nguyen S Gross J Delobel EKO Kruithof A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1 Blood 77 1991 528 532
47. WP Fay AD Shapiro JL Shih RR Schleef D Ginsburg Brief report: Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation N Engl J Med 327 1992 1729 1733
48. M Keeton Y Eguchi M Sawdey C Ahn DJ Loskutoff Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue Am J Pathol 142 1993 59 70
49. LA Erickson GJ Fici JE Lund TP Boyle HG Polites KR Marotti Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene Nature 346 1990 74 76 (letter)
50. A Hamsten U de Faire G Walldius G Dahlen A Szamosi C Landou M Blomback B Wiman Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 2 1987 3 9
51. DM Kerins Q Hao DE Vaughan Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV J Clin Invest 96 1995 2515 2520
52. DE Vaughan SA Lazos K Tong Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells J Clin Invest 95 1995 995 1001
53. EP Feener JM Northrup LP Aiello GL King Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells J Clin Invest 95 1995 1353 1362
54. RT van Leeuwen A Kol F Andreotti C Kluft A Maseri G Sperti Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells Circulation 90 1994 362 368
55. S Kagami T Kuhara K Okada Y Kuroda WA Border NA Noble Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells Kidney Int 51 1997 664 671
56. AD Hamdan WC Quist JB Gagne EP Feener Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta Circulation 93 1996 1073 1078
57. AR Kitching P Carmeliet SR Holdsworth PG Tipping Glomerulonephritis in mice with genetic deficiencies of the plasminogen/plasmin system J Am Soc Nephrol 7 1996 1738A (abstr)
58. AR Kitching SR Holdsworth VA Ploplis EF Plow D Collen P Carmeliet PG Tipping Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis J Exp Med 185 1997 963 968
59. ID Chant DV Milford PE Rose Plasminogen activator inhibitor activity in diarrhoea-associated haemolytic uraemic syndrome Q J Med 87 1994 737 740
60. Y Xu J Hagege B Mougenot J-D Sraer E Ronne E Rondeau Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney Kidney Int 50 1996 2011 2019
61. DE Vaughan The renin-angiotensin system and fibrinolysis Am J Cardiol 79 1997 12 16
62. PM Ridker CL Gaboury PR Conlin EW Seely GH Williams DE Vaughan Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function Circulation 87 1993 1969 1973
63. DE Vaughan J-L Rouleau PM Ridker JMO Arnold FJ Menapace MA Pfeffer Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction Circulation 96 1997 442 447
64. NJ Brown JV Gainer JH Nadeau DE Vaughan Plasminogen activator inhibitor antigen is increased in hypertensive African Americans with the ACE D allele Circulation 92 1995 I-552A (abstr)
65. NJ Samani JR Thompson L O'Toole K Channer KL Woods A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction Circulation 94 1996 708 712
66. P Eriksson B Kallin FM vanít Hooft P Bavenholm A Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci U S A 92 1995 1851 1855
67. H Kimura F Gejyo Y Suzuki S Suzuki R Miyazaki M Arakawa Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy Kidney Int 54 1998 1659 1669
68. DE Vaughan Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition Clin Cardiol 20 II suppl 2 1997 S1134 S1137
69. E Ritz D Fliser M Siebels Pathophysiology of hypertensive renal damage Am J Hypertens 6 suppl 1993 S241 S244
70. EP Feener GL King Vascular dysfunction in diabetes mellitus Lancet 350 suppl 1 1997 SI9 S13
71. BM Sibai L Kustermann J Velasco Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelet syndrome, and postpartum acute renal failure: Different clinical syndromes or just different names? Curr Opin Nephrol Hypertens 3 1994 436 445
72. M Nangaku SJ Shankland WG Couser RJ Johnson A new model of renal microvascular injury Curr Opin Nephrol Hypertens 7 1998 457 462
73. K Lemstrom P Koskinen P Häyry Molecular mechanisms of chronic renal allograft rejection Kidney Int 52 suppl 1995 S2 S10
74. GH Gibbons Endothelial function as a determinant of vascular function and structure: A new therapeutic target Am J Cardiol 79 1997 3 8
75. C Zoja A Remuzzi D Corna N Perico T Bertani G Remuzzi Renal protective effect of angiotensin-converting enzyme inhibition in aging rats Am J Med 92 suppl 4B 1992 S60 S63
76. D Heudes O Michel J Chevalier E Scalbert E Ezan J Bariety A Zimmerman B Corman Effect of chronic ANG-I-converting enzyme inhibition on aging processes. I. Kidney structure and function Am J Physiol 266 1994 R1038 R1051
77. JB Michel D Heudes O Michel P Poitevin M Philippe E Scalbert B Corman BI Levy Effect of chronic ANG-I-converting enzyme inhibition on aging processes. II. Large arteries Am J Physiol 267 1994 R124 R135
78. LJ Ma S Nakamura J Whitsett C Marcantoni J Davidson A Fogo Regression of glomerulosclerosis in aging by angiotensin II type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1) J Am Soc Nephrol 10 1999 576A (abstr)
79. S Nakamura I Nakamura H Nishimura D Vaughan A Fogo Plasminogen activator inhibitor-1 (PAI-1) is induced directly by angiotensin type 1 receptor in vivo J Am Soc Nephrol 9 1998 523A (abstr)